Novavax Inc vs ASML Holding NV
A head-to-head of Novavax Inc (NVAX) and ASML Holding NV (ASMLF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | NVAX | ASMLF |
|---|---|---|
| Market Cap | $1.30B | $541.44B |
| P/E (TTM) | 3.13 | 44.97 |
| Forward P/E | 2.58 | 40.16 |
| P/S | 1.16 | 16.07 |
| P/B | 33.20 | 22.44 |
| EV/EBITDA | 1.71 | 38.65 |
| Dividend Yield | — | 0.55% |
| Profit Margin | 39.19% | 30.86% |
| Gross Margin | 93.67% | 52.83% |
| Operating Margin | 50.14% | 34.60% |
| Revenue Growth (YoY) | +66.61% | +13.25% |
| FCF Yield | -19.24% | 1.65% |
| Debt / Equity | — | 12.99 |
| Current Ratio | 2.13 | 1.36 |
Share:
Compare Novavax Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.